AU2022323847A1 - Hypoallergenic peanut allergens, production and use thereof - Google Patents

Hypoallergenic peanut allergens, production and use thereof Download PDF

Info

Publication number
AU2022323847A1
AU2022323847A1 AU2022323847A AU2022323847A AU2022323847A1 AU 2022323847 A1 AU2022323847 A1 AU 2022323847A1 AU 2022323847 A AU2022323847 A AU 2022323847A AU 2022323847 A AU2022323847 A AU 2022323847A AU 2022323847 A1 AU2022323847 A1 AU 2022323847A1
Authority
AU
Australia
Prior art keywords
ara
seq
variant
amino acid
variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022323847A
Other languages
English (en)
Inventor
Moshe BEN DAVID
Zohar BIRON SOREK
Almog BREGMAN COHEN
Anna CHUPRIN
Gil DIAMANT
Yair GAT
Maayan KORMAN
Orly MARCU GARBER
Si NAFTALY KIROS
Yanay OFRAN
Lior ROSENFELD SHLAMKOVICH
Etai ROTEM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ukko Inc
Original Assignee
Ukko Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ukko Inc filed Critical Ukko Inc
Publication of AU2022323847A1 publication Critical patent/AU2022323847A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2022323847A 2021-08-03 2022-08-02 Hypoallergenic peanut allergens, production and use thereof Pending AU2022323847A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US202163228606P 2021-08-03 2021-08-03
US202163228604P 2021-08-03 2021-08-03
US63/228,606 2021-08-03
US63/228,604 2021-08-03
US202163284108P 2021-11-30 2021-11-30
US63/284,108 2021-11-30
US202163292441P 2021-12-22 2021-12-22
US63/292,441 2021-12-22
US202263311117P 2022-02-17 2022-02-17
US63/311,117 2022-02-17
US202263319393P 2022-03-14 2022-03-14
US202263319394P 2022-03-14 2022-03-14
US63/319,393 2022-03-14
US63/319,394 2022-03-14
PCT/IB2022/057144 WO2023012652A2 (en) 2021-08-03 2022-08-02 Hypoallergenic peanut allergens, production and use thereof

Publications (1)

Publication Number Publication Date
AU2022323847A1 true AU2022323847A1 (en) 2024-02-15

Family

ID=85155450

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022323847A Pending AU2022323847A1 (en) 2021-08-03 2022-08-02 Hypoallergenic peanut allergens, production and use thereof

Country Status (6)

Country Link
US (2) US20240390485A1 (https=)
EP (1) EP4380957A4 (https=)
JP (1) JP2024530926A (https=)
AU (1) AU2022323847A1 (https=)
CA (1) CA3226900A1 (https=)
WO (1) WO2023012652A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024178329A2 (en) * 2023-02-23 2024-08-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mutant ara h 2 and ara h 6 proteins and uses thereof
AU2024305143A1 (en) 2023-06-12 2026-01-08 Desentum Oy Hypoallergenic variants of major peanut allergen, ara h 2
WO2026080920A1 (en) 2024-10-13 2026-04-16 Ukko Inc. Mrna vaccine for peanut allergy treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002306850A1 (en) * 2001-03-16 2002-10-03 Panacea Pharmaceuticals Methods and reagents for decreasing clinical reaction to allergy
WO2005121166A1 (en) * 2004-06-10 2005-12-22 Monash University Novel immunointeractive molecules and uses thereof
EP2664624A1 (en) * 2012-05-15 2013-11-20 Biomay Ag Allergen variants
EP3563159A1 (en) * 2016-12-29 2019-11-06 Ukko Inc. Methods for identifying and de-epitoping allergenic polypeptides
US12398195B2 (en) * 2018-05-15 2025-08-26 Immunomic Therapeutics, Inc. Lamp constructs comprising allergens

Also Published As

Publication number Publication date
EP4380957A2 (en) 2024-06-12
JP2024530926A (ja) 2024-08-27
WO2023012652A2 (en) 2023-02-09
WO2023012652A3 (en) 2023-04-06
EP4380957A4 (en) 2025-09-03
US20240117020A1 (en) 2024-04-11
US20240390485A1 (en) 2024-11-28
CA3226900A1 (en) 2023-02-09

Similar Documents

Publication Publication Date Title
US20240390485A1 (en) Hypoallergenic peanut allergens, production and use thereof
Shade et al. A single glycan on IgE is indispensable for initiation of anaphylaxis
EP2022507A1 (en) Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy
Asturias et al. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen‐specific immunotherapy
TWI797124B (zh) 抗干擾素-γ之抗體及其應用
EP3641892A1 (en) Anti-allergen antibodies
KR20190129038A (ko) 신규 니코틴 분해 효소 변형체
DK2699681T3 (en) hypoallergenic
EP3256158A2 (en) Tolerance therapeutic for treating polypeptide induced allergy
Van Vaerenbergh et al. IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology
Ponce-López et al. Neutralization of crotamine by polyclonal antibodies generated against two whole rattlesnake venoms and a novel recombinant fusion protein
Nilsson et al. In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity
US20130004527A1 (en) Contiguous overlapping peptides for treatment of ragweed pollen allergy
CN117979981A (zh) 低过敏原性的花生过敏原、其产生及其用途
EP1620554B1 (en) Recombinant fel d 1 allergen
JP2025538106A (ja) ピーナッツに対する脱感作を誘導するための組成物及び方法
CN102079780B (zh) 蓖麻毒素a链突变体的构建及作为候选疫苗抗原
US20240400692A1 (en) Celiac disease epitopes
US20250206812A1 (en) Single domain antibodies against bee venom epitopes
WO2019135027A1 (en) Recombinant hypoallergenic equ c 1 polypeptides for use in the immunotherapy of horse allergy
AU2024305143A1 (en) Hypoallergenic variants of major peanut allergen, ara h 2
HK40120243A (zh) 用於免疫耐受的抗asgr1多肽和使用方法
CN117177988A (zh) 糖链修饰rbd和其应用
Nilsson et al. In Vitro Evolution of Allergy Vaccine Candidates, with Maintained